Cv6 Therapeutics (NI) Limited

Royaume‑Uni

 
Quantité totale PI 31
Rang # Quantité totale PI 46 136
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 041

Brevets

Marques

18 0
2 0
11 0
0
 
Dernier brevet 2023 - Combination therapy with deoxyur...
Premier brevet 2016 - Deoxyuridine triphosphatase inhi...

Derniers inventions, produits et services

2022 Invention Hydantoin containing deoxyuridine triphosphatase inhibitors. Provided herein are dUTPase inhibito...
2021 Invention Combination therapy with deoxyuridine triphosphatase inhibitors. Provided herein are deoxyuridin...
Invention Combination therapy with deoxyuridine triphosphatase inhibitors. Provided herein are deoxyuridine...
2020 Invention Nitrogen ring linked deoxyuridine triphosphatase inhibitors. Provided herein are dUTPase inhibito...
Invention Deoxyuridine triphosphatase inhibitors. Provided herein are dUTPase inhibitors, compositions comp...
Invention Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage. Provided herein are dUT...
Invention Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage. Provided herein are dUTPa...
2017 Invention Uracil containing compounds. Provided herein are dUTPase inhibitors, compositions comprising such...
Invention Amino sulfonyl compounds. Provided herein are dUTPase inhibitors, compositions comprising such co...
Invention 6-membered uracil isosteres. Provided herein are dUTPase inhibitors, compositions comprising such...